# A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China

> **NCT06082986** · — · COMPLETED · sponsor: **Xian-Janssen Pharmaceutical Ltd.** · enrollment: 200 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Ustekinumab

## Key facts

- **NCT ID:** NCT06082986
- **Lead sponsor:** Xian-Janssen Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-09
- **Primary completion:** 2024-06-05
- **Final completion:** 2024-06-05
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06082986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06082986, "A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06082986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*